Literature DB >> 13950710

Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine.

H GROOT, R B RIBERIRO.   

Abstract

The duration of immunity conferred by yellow fever vaccine is as yet undetermined. In this study the neutralizing and haemagglutination-inhibiting antibodies to yellow fever were investigated in 108 persons living in Pouso Alegre, Brazil, where yellow fever has never been reported. These persons had been vaccinated with 17D yellow fever vaccine between 27 December 1940 and 5 February 1941, but not again; and their antibody pattern was compared with that of 78 controls who had never been vaccinated. In the vaccinated group the majority had neutralizing and haemagglutination-inhibiting antibodies present in the serum, whereas in the unvaccinated group antibodies were all but completely absent. Heterologous antibodies to other viruses of Casal's Group B were also found, and the significance of this finding is discussed.

Entities:  

Keywords:  HEMAGGLUTINATION INHIBITION TESTS; NEUTRALIZATION TESTS; VACCINATION; YELLOW FEVER; YELLOW FEVER VIRUS

Mesh:

Substances:

Year:  1962        PMID: 13950710      PMCID: PMC2555840     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Virus isolations from forest mosquitoes in San Vicente de Chucuri, Colombia.

Authors:  H GROOT; A MORALES; H VIDALES
Journal:  Am J Trop Med Hyg       Date:  1961-05       Impact factor: 2.345

2.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

3.  Neutralizing antibodies against certain viruses in the sera of residents of India.

Authors:  K C SMITHBURN; J A KERR; P B GATNE
Journal:  J Immunol       Date:  1954-04       Impact factor: 5.422

4.  THE USE OF MICE IN TESTS OF IMMUNITY AGAINST YELLOW FEVER.

Authors:  W A Sawyer; W Lloyd
Journal:  J Exp Med       Date:  1931-09-30       Impact factor: 14.307

  4 in total
  20 in total

Review 1.  Advances and controversies in yellow fever vaccination.

Authors:  Emile F F Jonker; Leonardus G Visser; Anna H Roukens
Journal:  Ther Adv Vaccines       Date:  2013-11

Review 2.  Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection.

Authors:  J Erin Staples; Alan D T Barrett; Annelies Wilder-Smith; Joachim Hombach
Journal:  NPJ Vaccines       Date:  2020-07-06       Impact factor: 7.344

Review 3.  Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.

Authors:  Huabin Liang; Min Lee; Xia Jin
Journal:  Cell Mol Immunol       Date:  2015-10-05       Impact factor: 11.530

4.  Yellow fever virus: historical and current issues regarding recent epidemics and vaccination in Brazil.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Antonio Carlos R Vallinoto; Francisco De Paula Pinheiro
Journal:  Hum Vaccin Immunother       Date:  2019-11-14       Impact factor: 3.452

5.  Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.

Authors:  J D Poland; C H Calisher; T P Monath; W G Downs; K Murphy
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

Review 6.  Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

Authors:  Eduardo Gotuzzo; Sergio Yactayo; Erika Córdova
Journal:  Am J Trop Med Hyg       Date:  2013-09       Impact factor: 2.345

7.  Yellow fever in Pará State, Amazon region of Brazil, 1998-1999: entomologic and epidemiologic findings.

Authors:  P F Vasconcelos; A P Rosa; S G Rodrigues; E S Rosa; H A Monteiro; A C Cruz; V L Barros; M R Souza; J F Rosa
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

8.  A clinicopathological study of human yellow fever.

Authors:  T I Francis; D L Moore; G M Edington; J A Smith
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

9.  Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.

Authors:  Katherine B Gibney; Srilatha Edupuganti; Amanda J Panella; Olga I Kosoy; Mark J Delorey; Robert S Lanciotti; Mark J Mulligan; Marc Fischer; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2012-10-29       Impact factor: 2.345

10.  Recent rapid rise of a permethrin knock down resistance allele in Aedes aegypti in México.

Authors:  Gustavo Ponce García; Adriana E Flores; Ildefonso Fernández-Salas; Karla Saavedra-Rodríguez; Guadalupe Reyes-Solis; Saul Lozano-Fuentes; J Guillermo Bond; Mauricio Casas-Martínez; Janine M Ramsey; Julián García-Rejón; Marco Domínguez-Galera; Hilary Ranson; Janet Hemingway; Lars Eisen; William C Black IV
Journal:  PLoS Negl Trop Dis       Date:  2009-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.